Day: March 8, 2022

– New IND-enabling programs reinforce commitment to build a deep, broad and differentiated pipeline that transforms cancer immunotherapy leveraging company’s AI-powered platform – – SAFEbody® precision masking technology integrated across antibody-based modalities in POWERbody® candidates, designed to further enhance efficacy with secured safety – – Data show safe, powerful and durable immunotherapy for solid tumors can be achieved through combination of the fundamental mechanisms and pathways across the cancer immunity cycle – SAN DIEGO and SUZHOU, China, March 08, 2022 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced publication of four abstracts featuring preclinical data from...

NEW YORK, March 08, 2022 (GLOBE NEWSWIRE) — Medallion Financial Corp. (NASDAQ: MFIN, “Medallion Financial” or the “Company”), a finance company that originates and services loans in various consumer and commercial industries, announced today it would resume its existing Stock Repurchase Program. Under the repurchase program previously authorized by the board of directors, Medallion Financial may repurchase its outstanding shares of common stock from time to time in open market or privately-negotiated transactions, including accelerated share repurchase transactions, block trades, or pursuant to 10b5-1 trading plans. Any repurchases will be at management’s discretion and will be subject to market conditions, the price of the Company’s shares and other factors. The stock repurchase program may be modified, suspended or terminated...

            — Oral presentation to discuss how translational immunology data enabled iterative development of an optimized, KRAS-specific version of “off-the shelf” vaccine candidate; the optimized version is now in Phase 2 testing for solid tumor patients — EMERYVILLE, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, taking place April 8-13, 2022, in New Orleans, Louisiana. In the poster presentations, Gritstone representatives will review data from individualized neoantigen program, GRANITE, and the “off-the-shelf” neoantigen...

Location of gunfire based on ShotSpotter Alert vs. Forensic Report Real-Time Alert May 31, 2020Location of gunfire based on ShotSpotter Alert vs. Forensic Report Detailed Forensic Report February 8, 2021FREMONT, Calif., March 08, 2022 (GLOBE NEWSWIRE) — ShotSpotter, Inc. (Nasdaq: SSTI), a leader in precision policing technology solutions that enable law enforcement to more effectively respond to, investigate, and deter crime, today announced that the Associated Press has joined a growing list of media outlets that have retracted, corrected, or clarified their reporting of a demonstrably false claim that was originally published by VICE Media. The global news organization also corrected its reporting to explain that a ShotSpotter forensic report was in fact admissible as evidence in a 2014 California case. After correcting...

Tandem Adhesive Laminator The new Tandem Adhesive Laminator, which will be ready for production this spring, will improve run speeds, cure time, and increase capacity. The machine is in a temperature and humidity-controlled environment for top-performance.MENOMONEE FALLS, Wis., March 08, 2022 (GLOBE NEWSWIRE) — Glenroy® Inc., a leading sustainable flexible packaging company has announced a significant increase in capacity with the addition of a Tandem Adhesive Laminator, allowing them to better serve both existing and new customers. “Our recent expansion, and specifically, the addition of the Tandem Adhesive Laminator, is accelerating our growth in high-barrier film laminations, recyclable pouches, and our stand-up pouch capabilities,” said Evan Arnold, VP of Business Development at Glenroy. “This investment will allow us to...

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (“Pure Extracts” or the “Company”) (CSE: PULL) (XFRA: A2QJAJ) is pleased to announce that it has completed a non-brokered private placement offering (the “Offering”) of special warrants (each, a “Special Warrant”). In connection with the Offering, the Company issued an aggregate of 5,937,001 Special Warrants at a price of $0.075 per Special Warrant, for aggregate gross proceeds of $445,275. The Company also closed its offer to settle an aggregate of $206,433in debt owed to certain creditors (the “Debt Settlement”) in exchange for units (the “Debt...

CAMBRIDGE, Mass. and BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the publication of two abstracts for its upcoming poster presentations at the American Association for Cancer Research (AACR) Annual Meeting. The meeting will be hosted April 8-13, 2022 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The first poster presentation will highlight new nonclinical data on the unique properties of bezuclastinib that differentiate it from other KIT inhibitors. Bezuclastinib is currently under clinical investigation in Advanced Systemic Mastocytosis (NCT04996875), Nonadvanced Systemic Mastocytosis (NCT05186753), and imatinib-resistant Gastrointestinal Stromal...

ATHENS, Greece, March 09, 2022 (GLOBE NEWSWIRE) — Imperial Petroleum Inc. (Nasdaq: IMPP) (the “Company”) announced today that it has entered into an agreement to acquire two M.R. refined petroleum product tankers, built at SLS Shipbuilding, South Korea in 2008 and at Shin Kurushima Dockyard, Japan in 2011 respectively, with an aggregate capacity of approximately 97,000 dwt, from Brave Maritime for an aggregate purchase price of about $31 million, with delivery on a charter free basis expected by end of May 2022. The Company expects to finance the purchase price with cash-on-hand and new senior secured bank debt for which it is in discussions to secure with an international financial institution. The transaction with Brave Maritime, which is affiliated with members of the Vafias family, was approved by the Company’s audit committee...

Data include results from preclinical studies of KB-0742 in MYC-amplified cancers, including small-cell lung, triple-negative breast and ovarian, as well as lymphomaPosters also feature data from preclinical chordoma and sarcoma modelsKB-0742 is being evaluated in an ongoing Phase 1/2 trial SAN MATEO, Calif. and CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today announced that it will present preclinical data on its internally discovered, highly selective, oral cyclin dependent kinase 9 (CDK9) inhibitor, KB-0742, in four poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022, being held April 8-13 in New Orleans. Kronos Bio is currently evaluating...